Results 1 to 10 of about 10,600 (216)

Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: Previously, secondary prevention of herpes zoster required live-attenuated vaccination, which is contraindicated in immunocompromised populations.
Rebecca I. Chen   +3 more
doaj   +6 more sources

Lichen planus following recombinant zoster vaccine [PDF]

open access: yesJAAD Case Reports
Charli C. Gruen, 2d Lt, USAF, BS   +2 more
doaj   +3 more sources

Herpes zoster ophthalmicus following recombinant zoster vaccine: A case report and brief literature review [PDF]

open access: yesIDCases
Purpose: Immunizations have long been pivotal in preventing diseases like HZ (herpes zoster), caused by VZV (varicella zoster virus). This study aims to evaluate the efficacy and safety of the RZV (recombinant zoster vaccine) compared to the ZVL (zoster ...
Joshua M. Garcia, Ramez I. Haddadin
doaj   +4 more sources

Uveitis reactivation following recombinant zoster vaccination

open access: yesAmerican Journal of Ophthalmology Case Reports, 2021
Purpose: Describe three cases of uveitis reactivation following immunization with recombinant zoster vaccine (RZV). Observations: One patient developed reactivation of previously controlled multifocal choroiditis within one week of receiving RZV ...
Paige J. Richards   +3 more
doaj   +3 more sources

Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice [PDF]

open access: yesViruses
Varicella-zoster virus (VZV) is a human neurotropic herpesvirus. The primary infection with VZV causes chickenpox and establishes latency in sensory and dorsal root ganglia.
Yaru Quan   +7 more
doaj   +2 more sources

Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Herpes zoster (HZ) is a debilitating vaccine-preventable disease. Impairment of cell-mediated immunity, as observed with aging and immunosuppressive disorders and therapies, increases risk.
Agnes Mwakingwe-Omari   +4 more
doaj   +2 more sources

The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide [PDF]

open access: yesInfectious Diseases and Therapy
Introduction Herpes zoster (HZ, Shingles) is a vaccine-preventable viral disease impacting patients’ quality of life owing to pain and rash. An estimated 15 million HZ cases occur annually in individuals aged ≥ 50 years worldwide.
Nikolaos Giannelos   +4 more
doaj   +2 more sources

Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines

open access: yesViruses, 2022
Infection with varicella zoster virus typically occurs in children and it can cause primary varicella infection or “chickenpox”, or it can reactivate later in life and cause herpes zoster or “shingles”.
Yasmin Marra, Fawziah Lalji
doaj   +1 more source

Herpes zoster vaccination. An update

open access: yesPrzegląd Dermatologiczny, 2022
Herpes zoster/shingles is a cutaneous condition caused by the reactivation of varicella zoster virus. The condition mostly occurs when the cell mediated immunity towards varicella zoster virus, which was developed during the varicella zoster virus ...
Khairuddin Djawad   +5 more
doaj   +1 more source

Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration [PDF]

open access: yes, 2017
Varicella zoster virus (VZV) is a highly prevalent human pathogen that establishes latency in neurons of the peripheral nervous system. Primary infection causes varicella whereas reactivation results in zoster, which is often followed by chronic pain in ...
Bauerfeind, R. (Rudolf)   +19 more
core   +4 more sources

Home - About - Disclaimer - Privacy